homocysteine has been researched along with amyloid beta-peptides in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (60.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agnati, LF; Filaferro, M; Forni, A; Franco, R; Fuxe, K; Genedani, S; Leo, G; Woods, AS | 1 |
| Acres, J; Almeida, OP; Flicker, L; Jamrozik, K; Martins, RN; Norman, P; Taddei, K; Thomas, J; Vasikaran, SD | 1 |
| Campbell, S; Greenberg, SM; Hyman, BT; Irizarry, MC; Raj, S; Stampfer, M; Viswanathan, A | 1 |
| Alexopoulos, P; Bleich, S; Günther, F; Jessen, F; Kneib, T; Kornhuber, J; Kurz, A; Lewczuk, P; Peters, O; Popp, J; Richter-Schmidinger, T; Wiltfang, J; Wolf, S | 1 |
| Handels, R; van Rossum, IA; Visser, PJ; Vos, S | 1 |
| Bomba, M; Conti, E; Ferrarese, C; Nacinovich, R; Neri, F; Raggi, ME; Tremolizzo, L | 1 |
| Atienza, M; Cantero, JL; Llado-Saz, S | 1 |
| Chi, J; Gao, F; Guo, H; Lin, H; Lin, N; Luo, H; Ni, T; Zhang, J | 1 |
| Agnati, LF; Andreoli, N; Astancolle, S; Carone, C; Davalli, P; Filaferro, M; Fuxe, K; Genedani, S; Leo, G | 1 |
| Barrow, CJ; Beyreuther, K; Masters, CL; Mok, SS; Small, DH; Turner, BJ | 1 |
1 review(s) available for homocysteine and amyloid beta-peptides
| Article | Year |
|---|---|
Biomarkers as predictors for conversion from mild cognitive impairment to Alzheimer-type dementia: implications for trial design.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Clinical Trials as Topic; Cognition Disorders; Disease Progression; Homocysteine; Humans; Lipid Metabolism; Peptide Fragments; tau Proteins | 2010 |
2 trial(s) available for homocysteine and amyloid beta-peptides
| Article | Year |
|---|---|
B-vitamins reduce plasma levels of beta amyloid.
Topics: Aged; Aged, 80 and over; Amyloid beta-Peptides; Double-Blind Method; Homocysteine; Humans; Longitudinal Studies; Peptide Fragments; Vitamin B Complex; Vitamin B Deficiency | 2008 |
Plasma Abeta, homocysteine, and cognition: the Vitamin Intervention for Stroke Prevention (VISP) trial.
Topics: Aged; Amyloid beta-Peptides; Cognition; Dose-Response Relationship, Drug; Double-Blind Method; Down-Regulation; Female; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Osmolar Concentration; Peptide Fragments; Pyridoxine; Stroke; Treatment Failure; Vitamin B 12; Vitamin B Complex; Vitamins | 2009 |
7 other study(ies) available for homocysteine and amyloid beta-peptides
| Article | Year |
|---|---|
Abeta peptides as one of the crucial volume transmission signals in the trophic units and their interactions with homocysteine. Physiological implications and relevance for Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain; Cell Communication; Corpus Striatum; Extracellular Space; Glial Fibrillary Acidic Protein; Homocysteine; Male; Nerve Net; Neuroglia; Neurons; Pain Threshold; Peptide Fragments; Plaque, Amyloid; Protein Structure, Secondary; Rats; Rats, Sprague-Dawley; Tyrosine 3-Monooxygenase | 2007 |
Plasma homocysteine and cerebrospinal fluid neurodegeneration biomarkers in mild cognitive impairment and dementia.
Topics: Aged; Amyloid beta-Peptides; Biomarkers; Chromatography, High Pressure Liquid; Creatinine; Dementia; Enzyme-Linked Immunosorbent Assay; Female; Folic Acid; Germany; Homocysteine; Humans; Immunoassay; Linear Models; Male; Middle Aged; Nephelometry and Turbidimetry; Nerve Degeneration; Peptide Fragments; tau Proteins; Vitamin B 12 | 2009 |
Beta-amyloid plasma levels in adolescents with anorexia nervosa of the restrictive type.
Topics: Adolescent; Amyloid beta-Peptides; Anorexia Nervosa; Apolipoproteins E; Chi-Square Distribution; Child; Female; Homocysteine; Humans; Leptin; Linear Models; Outpatients; Peptide Fragments; Psychiatric Status Rating Scales; Young Adult | 2015 |
Increased levels of plasma amyloid-beta are related to cortical thinning and cognitive decline in cognitively normal elderly subjects.
Topics: Aged; Aging; Alzheimer Disease; Amyloid beta-Peptides; Cerebral Cortex; Cognition; Cognition Disorders; Female; Homocysteine; Humans; Male; Peptide Fragments; Risk Factors | 2015 |
Herpud1 deficiency could reduce amyloid-β40 expression and thereby suppress homocysteine-induced atherosclerosis by blocking the JNK/AP1 pathway.
Topics: Amyloid beta-Peptides; Animals; Atherosclerosis; Cells, Cultured; Homocysteine; Human Umbilical Vein Endothelial Cells; Humans; Male; MAP Kinase Signaling System; Membrane Proteins; Mice; Mice, Inbred C57BL; Peptide Fragments | 2020 |
Hyper-homocysteinemia alters amyloid peptide-clusterin interactions and neuroglial network morphology and function in the caudate after intrastriatal injection of amyloid peptides.
Topics: Amyloid beta-Peptides; Animals; Behavior, Animal; Benzothiazoles; Caudate Nucleus; Clusterin; Drug Interactions; Food, Formulated; Homocysteine; Hyperhomocysteinemia; Male; Methionine; Models, Biological; Pain Measurement; Peptide Fragments; Rats; Rats, Sprague-Dawley; Reaction Time; Thiazoles | 2007 |
Toxicity of substrate-bound amyloid peptides on vascular smooth muscle cells is enhanced by homocysteine.
Topics: Amyloid beta-Peptides; Animals; Apoptosis; Caspase 3; Caspases; Cell Adhesion; Cells, Cultured; Homocysteine; Hydrogen Peroxide; Membrane Glycoproteins; Muscle, Smooth, Vascular; Peptide Fragments; Rats; Rats, Inbred WKY; Rats, Sprague-Dawley | 2002 |